Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Renal Insufficiency 1Malignant Tumor of Ill-defined Site 1Lung Neoplasms 1Leukemia, Prolymphocytic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

ixabepilone 2aldesleukin 2Oxaliplatin 2sargramostim 1rF-B7.1 vaccine 1peginterferon alfa-2b 1indolepropanol phosphate 1fludarabine phosphate 1birinapant 1becatecarin 1alvocidib 1Topotecan 1Sorafenib 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1O(6)-benzylguanine 1Nitroarginine 1Methods 1Magnetic Resonance Spectroscopy 1Lapatinib 1Interleukin-2 1Ifosfamide 1Granulocyte-Macrophage Colony-Stimulating Factor 1Gemcitabine 1Fluorodeoxyglucose F18 1Filgrastim 1Early Intervention, Educational 1Docetaxel 1Decitabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Unspecified Adult Solid Tumor, Protocol Specific × Pharmacogenomic Testing × Clear all
NCT01705106 2018-05-30

Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies

University of Chicago

Phase 1 Terminated
21 enrolled 5 charts
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡